MMMario Maldonado

Mario Maldonado

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mario Maldonado has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Ashok Balasubramanyam

    Division of Endocrinology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA

    3 shared publications
  • Ashok Balasubramanyam

    Baylor College of Medicine, Houston, TX

    2 shared publications
  • A. Balasubramanyam

    Division of Endocrinology, Department of Medicine, Baylor College of Medicine and

    1 shared publication
  • Archana Rao

    Division of Endocrinology, Baylor College of Medicine, and Endocrine Service, Ben Taub General Hospital, Houston, Texas, USA

    1 shared publication
  • C. C. Case

    Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA

    1 shared publication
  • Erica R. Chong

    Division of Endocrinology, Department of Medicine, Baylor College of Medicine, Houston, Texas

    1 shared publication

Latest Publications

  • Factors associated with insulin discontinuation in subjects with ketosis‐prone diabetes but preserved β‐cell function

    by M. R. Maldonado, M. E. Otiniano, F. Cheema, L. Rodriguez, A. Balasubramanyam

    Aim  To evaluate factors predictive of insulin discontinuation in subjects with ketosis‐prone Type 2 diabetes.Methods  One hundred and six subjects with ketosis‐prone Type 2 diabetes were recruited during the index episode of diabetic ketoacidosis (DKA). All subjects were followed in a special clinic for at least 6 months. If the subject's glycaemic control reached specified glycaemic goals, exogenous insulin was gradually decreased until discontinuation. Baseline and follow‐up characteristics were compared between the off‐insulin and the on‐insulin groups.Results  At the end of the follow‐up period (915 ± 375 days) insulin was discontinued in 47% subjects. Subjects in the off‐insulin group were significantly older at the time of diagnosis of diabetes. In the off‐insulin group the majority of subjects were newly diagnosed with diabetes. After 6 months of follow‐up, subjects in the off‐insulin group had significantly lower mean HbA1c, higher mean C‐peptide‐to‐glucose ratio and had more clinic visits per year. In the proportional hazard analysis, new‐onset diabetes [hazard ratio (HR) 1.54; 95% confidence interval (CI) 1.02–2.45], and a higher C‐peptide‐to‐glucose ratio at 6 months of follow‐up (HR 1.77; 95% CI 1.22–2.63) were significant predictors of insulin discontinuation.Conclusions  In subjects with ketosis‐prone Type 2 diabetes, the best predictors of insulin discontinuation are having new‐onset diabetes, and higher β‐cell functional reserve (as measured by the C‐peptide‐to‐glucose ratio).


  • Predictors of glycaemic control in indigent patients presenting with diabetic ketoacidosis

    by M. Maldonado, S. D'AMico, M. Otiniano, A. Balasubramanyam, L. Rodriguez, E. Cuevas

    Aim:  To derive predictors of good glycaemic control in patients presenting with diabetic ketoacidosis (DKA) followed prospectively in a specialized clinic. Methods:  One hundred and sixty‐one adult patients were admitted during a 31‐month period and followed for at least 12 months. After 1 year, the patients were classified into three groups: good control (GC) (HbA1c ≤ 7%), intermediate control (IC) (HbA1c 7–9%) and poor control (PC) (HbA1c > 9%). Characteristics of patients in the three groups were compared both at baseline and during follow‐up. Results:  At 12 months, 36% of the patients were classified as GC, 27% as IC and 37% as PC. GC patients had higher fasting serum C‐peptide levels 0.7 ± 0.54 compared to 0.38 ± 0.29 and 0.16 ± 0.21 nmol/l, respectively, for the IC and PC patients (p < 0.0001). A higher proportion GC patient had a C‐peptide level greater than 0.33 nmol/l than that for IC and PC patients (86, 61 and 19%, respectively; p < 0.0001). Exogenous insulin was safely discontinued in 50, 30 and 3% of patients, respectively, in the GC, IC and PC groups (p < 0.0001). Compliance with life‐style interventions was higher in the GC than that in IC and PC patients (87, 41 and 5%, respectively; p < 0.0001). In the logistic regression analysis, predictors of good glycaemic control were having baseline fasting serum C‐peptide value ≥0.33 mmol/l, OR: 3.01 (95% CI 1.07–8.55, p = 0.03) and compliance with life‐style interventions OR 12.66 (95% CI 3.73–51.57, p = 0.0001). Conclusion:  Among adult patients with DKA, significant predictors of good glycaemic control are preserved β‐cell function and compliance with life‐style modifications.


    • 1 January 2004
      • Vol. 14  (2) , 243-9

    Characteristics of ketosis-prone diabetes in a multiethnic indigent community.

    by Mario R Maldonado, Max E Otiniano, Rebekah Lee, Lucille Rodriguez, Ashok Balasubramanyam

    To compare demographic and clinical characteristics among 3 ethnic groups of indigent patients exhibiting diabetic ketoacidosis (DKA), in Houston, Texas. Over a span of 3.5 years, 321 patients were interviewed at the time of admission for DKA. Demographic, clinical, and biochemical data and measures of pancreatic beta-cell function were obtained at baseline and during follow up. Pearson's chi-square test, or one-way ANOVA, were used, as appropriate, to evaluate group differences. Of the 321 subjects, 44% were African-American, 40% were Hispanic, and 16% were Caucasian. A significantly higher proportion of Hispanics had preserved beta-cell function, compared to African Americans and Caucasians (51% vs 32% and 32%, respectively; P = .002). This difference, present at the time of the admission, was maintained through follow up. In a multivariate analysis, Hispanic ethnicity (OR 3.61; 95% CI 1.48-9.29) was a significant predictor of preserved beta-cell function. In addition, Hispanics were less likely to develop DKA as a result of treatment non-compliance, and more likely to have DKA precipitated by an acute illness. Our findings indicated that ethnicity is associated with significant differences in the pathophysiologic and clinical characteristics of indigent, ketosis-prone patients. Hispanic ethnicity was found to be associated with greater beta-cell functional reserve, and less dependence on chronic insulin therapy.


  • Open Access

    Economic Impact of Diabetic Ketoacidosis in a Multiethnic Indigent Population

    by Mario R. Maldonado, Erica R. Chong, Melissa A. Oehl, Ashok Balasubramanyam

    OBJECTIVE—Diabetic ketoacidosis (DKA) is a common complication of diabetes. We analyzed the inpatient costs of treating DKA in a multiethnic, indigent population in Houston, Texas. RESEARCH DESIGN AND METHODS—We measured the cost of resources utilized for all patients admitted to our hospital with DKA from 1 January to 31 December 1998. We also analyzed their medical records to determine the factors that precipitated the episode of DKA and then grouped them into three categories: acute illnesses, noncompliance with diabetes treatment, and new-onset diabetes. The data were analyzed by one-way ANOVA. The Tukey-Kramer procedure was used for post hoc multiple comparisons. RESULTS—There were 167 admissions for DKA. The mean age was 40 ± 13 years. The ethnic distribution was 49% African American, 32% Hispanic American, and 18% white. The total inhospital cost of treating DKA was $1,816,255. The mean cost per hospitalization was $10, 876 ± 11,024. The frequency distribution by category of DKA-precipitating factor was 18% acute illness, 59% noncompliance, and 23% new onset. There were differences in mean cost of DKA associated with the three categories: $20,864 ± 17,910 for acute illness, $11,863 ± 8,701 for new onset, and $7,470 ± 6,300 for noncompliance (P < 0.0001). The total cost for each category was $671,375 for acute illness, $694,082 for noncompliance, and $450,798 for new onset. CONCLUSIONS—DKA is an expensive complication among indigent, multiethnic diabetic patients. Although the mean cost per admission was lowest for DKA precipitated by noncompliance, this causal category was responsible in sum for the greatest portion of the economic burden.


  • Diabetic ketoacidosis associated with Metabolife: a report of two cases

    by C. C. Case, M. Maldonado

    Aim: To describe two cases of diabetic ketoacidosis in newly diagnosed type 1‐ and type‐2‐diabetic individuals associated with Metabolife‐356 ® . Methods: We report the acute hospitalizations and clinical courses of two individuals with diabetic ketoacidosis taking Metabolife‐356 ® . Results: Both patients presented without a previous diagnosis of diabetes mellitus. One patient clinically has type 1 diabetes (positive islet cell antibodies and subnormal pancreatic beta cell function to glucagon stimulation) and is treated with insulin. The second patient, after 5 days of treatment with intravenous insulin of up to 25 units per hour, is now treated with oral medications. Several possible mechanisms may exist, including the increases in catecholamines and in blood glucose after ingestion of the ingredients of these supplements. Recent clinical trial data shows an increase in blood glucose (in non‐diabetics) with these supplements despite significant weight loss at 8 weeks, although no association with diabetes mellitus has been shown in these closely monitored studies. Conclusions: Although no precipitating factor of diabetic ketoacidosis was found in these individuals, the dietary supplement Metabolife cannot be established as a precipitant. However, patients with diabetes should take this supplement only after consultation with their health care provider, as stated on the product label. Most individuals using this supplement meet the current criteria for screening to detect undiagnosed diabetes mellitus and should consider these tests.